Ajanta Pharma jumps 3% on amalgamation approval
Monday, March 20, 2017, 3:19 PM
Ajanta Pharma gained 3.2% in Monday’s trade as the company’s board of directors approved amalgamation of Gabs Investments with itself. The company for FY 2016-17 has also approved payment of interim dividend at Rs 7 per share. Ajanta Pharma on the NSE is currently trading at Rs 1846 per share and is up by Rs 52 per share or 2.9%.